Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma

por Chen, L, Zhao, Y, Halliday, G C, Berry, P, Rousseau, R F, Middleton, S A, Nichols, G L, Del Bello, F, Piergentili, A, Newell, D R, Lunec, J, Tweddle, D A
Publicado 2014